A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.
Women with breast cancer must often make complex decisions about surgery and treatment options during an already stressful time in their lives, and many of these women may turn to the wide variety of materials available online. New research presented at the American College of Surgeons (ACS) Clinical Congress 2023 has found that reliable educational materials about breast surgery are not only difficult to assess but are also presented at much higher reading levels than recommended.
Women with diets during middle age designed to lower blood pressure were about 17 percent less likely to report memory loss and other signs of cognitive decline decades later, a new study finds.
This special edition features upcoming oral presentations by MD Anderson researchers at the 2023 European Society for Medical Oncology (ESMO) Congress focused on clinical advances across a variety of cancer types.
Monica M. Bertagnolli, MD, FACS, a renowned oncologic surgeon and cancer researcher who has served as the director of the National Cancer Institute (NCI) since October 2022, will receive the prestigious American College of Surgeons (ACS) Owen H. Wangensteen Scientific Forum Award at the ACS Clinical Congress 2023 in Boston, Massachusetts. Each year, the ACS Scientific Forum Committee gives this award to an individual who exemplifies the clinical, research, and educational achievements of a successful academic surgeon.
Oula-Mount Sinai West partnership offers patients the best of obstetrics and midwifery, with midwife-led delivery supported by leading hospital's expertise and resources
Women with a high genetic predisposition for blood clots are six times more likely to develop a blood clot during the first two years of using contraceptive pills according to a new study from Uppsala University. The results have been published in the American Journal of Obstetrics and Gynaecology
UNC School of Medicine researchers led an international team of researchers to conduct the largest-ever meta-analyses of genome-wide association studies (GWAS) to investigate the genetic architecture of PPD.
Herceptin has saved millions of women’s lives by targeting cancer at its genetic roots. In this interview, Dr. Slamon talks about the paradigm-shifting approach to cancer treatment and how the discovery has opened up an entirely new area of research.
Not for public release
This news release is embargoed until 19-Oct-2023 5:00 AM EDT
Released to reporters: 18-Oct-2023 10:05 AM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 19-Oct-2023 5:00 AM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
A teacher, a pharmacist, a public health advocate and a diabetes care and education specialist, Mandy Reece, PharmD, is adding one more title to her resume. Recently diagnosed with breast cancer, Reece has become even more adamant about advocating for yearly mammograms for adult women.
A first-of-its kind survey effort led by the University of Chicago Medicine and partners around the globe will help scientists better focus their research to answer the most pressing unknown questions about menopause.
Chronic inflammation of the skin, or Hidradenitis Suppurativa (HS), disproportionately affects women and people of color. It can be debilitating, negatively impacting suffers’ quality of life, physical function, work productivity, and the social and emotional wellbeing.
Can exercise, intermittent fasting and other lifestyle changes help patients with advanced breast cancer better tolerate side effects from treatment? A new $4-million NCI-funded study at Sylvester Comprehensive Cancer Center seeks to answer that question.
Not for public release
This news release is embargoed until 16-Oct-2023 5:00 PM EDT
Released to reporters: 10-Oct-2023 2:00 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 16-Oct-2023 5:00 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Women are nearly 50% more likely than men to develop depression after suffering a concussion or other traumatic brain injury (TBI), according to an analysis of nine studies and nearly 700,000 people presented at the ANESTHESIOLOGY® 2023 annual meeting.
A new mouse model of infection with the COVID-19-causing SARS-CoV-2 virus during pregnancy tracks closely the disease course doctors have observed in SARS-CoV-2-infected pregnant patients, and suggests that treatment with the antiviral Paxlovid provides protection for both mother and child.
Two simple solutions could help prevent severe bleeding (postpartum hemorrhage) after cesarean delivery, suggests research presented at the ANESTHESIOLOGY® 2023 annual meeting. As the leading cause of maternal mortality in the U.S. at the time of birth, postpartum hemorrhage is more common after cesarean deliveries than vaginal births.
A new study has discovered large variations in how pregnancy can affect women’s perceptions of their own body, including experiences of negative body image.
Reversing historical patterns, new findings led by researchers at the American Cancer Society show higher lung cancer incidence in women than in men has not only continued in adults younger than 50 years, but now extends to women 50 to 54 years of age in the United States. The findings are published today in the Journal of the American Medical Association (JAMA) Oncology.
Exposure to traffic-related air pollution during pregnancy is associated with serious neonatal complications, according to a study by UT Southwestern Medical Center researchers that matched records from more than 60,000 births with air-monitoring data.
A woman of average risk should get her first mammogram at age 40. But how do you know your risk? A Penn State Health expert talks about what younger women can do.
Do you know your risk for breast and ovarian cancer? How about steps you can take to reduce your chances of developing cancer or what a family history might mean for your risk of the disease?
Susan G. Komen® will hold a Metastatic Breast Cancer Impact Series Conference in Philadelphia that will include sessions with leading experts, survivor stories, wellness guidance, and interactive Q&A, offering attendees valuable insights, inspiration, practical tips, and community support.
Pregnancy complications such as preeclampsia and gestational diabetes have recently been associated with a higher risk of developing heart disease later in life. But a new Northwestern Medicine study has found obesity before or during pregnancy is the actual root cause of future cardiovascular disease.
Immune cells play a key role during pregnancy, adjusting immune system response in a way that enables the fetus to develop while also protecting the parent and fetus from outside assaults like viruses.
Inflammatory breast cancer is a rare type of breast cancer. It only accounts for one to five percent of all breast cancer cases, but it’s important to know your risk and the warning signs, as this form of the disease is aggressive, fast-growing, and hard to detect early. For October, during Breast Cancer Awareness Month, the American Cancer Society is highlighting IBC to help women be aware of this invasive cancer.
A study by UT Southwestern Medical Center researchers is the first to demonstrate the long-term efficacy of electrofulguration, a minimally invasive outpatient procedure that treats chronic urinary tract infections (UTIs) among postmenopausal women.
A groundbreaking study presented today by University of North Carolina (UNC) School of Medicine researchers at the XXIV FIGO World Congress of Gynecology and Obstetrics could revolutionize pregnancy care, especially in areas with limited resources.
Mercy's breast health experts Dr. Deepa Masrani and Dr. Wen C. Liang are guests for the October 2023 edition of "Medoscopy"; October is National Breast Cancer Awareness Month.
Catherine Spong, M.D., Chair and Professor of Obstetrics and Gynecology at UT Southwestern Medical Center, has been elected to the National Academy of Medicine (NAM) in recognition of her contributions to the field of maternal-fetal medicine, her leadership in women’s health research, and her dedication to advancing health care for mothers and babies.
Three decades after discoveries linking mutations in the BRCA1 gene to breast and ovarian cancer susceptibility, research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has pinpointed the molecular mechanism by which a large portion of these mutations cause cancers in women.
By: Anna Prentiss, Rodrigo Santa Maria | Published: October 6, 2023 | 4:13 pm | SHARE: According to the Centers for Disease Control and Prevention, more than 240,000 new breast cancer cases in women and 2,100 men are diagnosed annually in the United States alone. Though this number has been decreasing over recent years, the disease is still the second-leading cause of death from cancer among women in the United States.
The offspring of adolescent and young adult women with a history of cancer face a higher risk of birth defects, according to new research from UTHealth Houston.
Researchers at University of Galway have taken a significant step forward in the management of gestational diabetes mellitus after a clinical trial involving pregnant women provided new hope for expectant mothers suffering the condition.
This fall, Living Beyond Breast cancer, the national patient information and support organization, is providing expert patient perspectives on patients living with breast cancer. Connect with members of the LBBC community to discuss living with breast cancer, racial equity in breast cancer health, and body image and reconstruction.
A device has been created that could carry out Clinical Breast Examinations (CBE).
Not for public release
This news release is embargoed until 3-Oct-2023 5:30 PM EDT
Released to reporters: 28-Sep-2023 8:05 AM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 3-Oct-2023 5:30 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
A breast cancer researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center received a five-year, $2.2 million grant from the National Cancer Institute to examine how certain immune cells support metastatic breast cancer development and how to stop it.
A new program led by Indiana University School of Medicine faculty will provide more support for mothers and babies in the Indiana Women's Prison, thanks to a new $468,000 grant from the Early Years Initiative from Early Learning Indiana.
UVA Health researchers have developed a powerful new tool to understand how medications affect men and women differently, and that will help lead to safer, more effective drugs in the future.